Literature DB >> 29274473

Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain.

Hanshuang Shao1, Anna Wang2, Douglas Lauffenburger3, Alan Wells4.   

Abstract

Tyro3, a member of TAM receptor tyrosine kinase family, has been implicated in the regulation of melanoma progression and survival. In this study, we sought the molecular mechanism of Tyro3 effects avoiding endogenous background by overexpression of Tyro3 in fibroblasts that have negligible levels of Tyro3. This introduction triggers the tyrosyl-phosphorylation of ACTN4, a member of actin binding protein family involved in motility, a behavior critical for invasive progression, as shown by siRNA to Tyro3 limiting melanoma cell migration and invasion. Tyro3-mediated phosphorylation of ACTN4 required FAK activation at tyrosine 397 and the EGF receptor cascade, but not EGFR ligand binding. Using PCR-based mutagenesis, the sites of Tyro3-mediated ACTN4 phosphorylation were mapped to ACTN4 tyrosine 11 and 13, and this occurs in conjunction with EGF-mediated phosphorylation on Y4 and Y31. Interestingly, Tyro3-mediated phosphorylation only slightly decreases the actin binding activity of ACTN4. However, this rendered the phosphorylated ACTN4 resistant to the m-calpain cleavage between Y13 and G14, a limited proteolysis that prevents growth factor regulation of ACTN4 interaction with F-actin. Overexpression of both WT ACTN4 and ACTN4Y11/13E, a mimic of ACTN4 phosphorylated at tyrosine 11 and 13, in melanoma WM983b cells resulted in a likely mesenchymal to amoeboidal transition. ACTN4Y11/13E-expressing cells were more amoeboidal, less migratory on collagen I gel coated surface but more invasive through collagen networks. In parallel, expression of ACTN4Y11/13E, in ACTN4 knockdown melanoma WM1158 cells resulted in an increase of invasion compared to WT ACTN4. These findings suggest that Tyro3-mediated phosphorylation of ACTN4 is involved in invasion of melanoma cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actinin-4; Migration; Phosphorylation; Tyro3

Mesh:

Substances:

Year:  2017        PMID: 29274473      PMCID: PMC5803314          DOI: 10.1016/j.biocel.2017.12.014

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  45 in total

Review 1.  Cutting to the chase: calpain proteases in cell motility.

Authors:  Angela Glading; Douglas A Lauffenburger; Alan Wells
Journal:  Trends Cell Biol       Date:  2002-01       Impact factor: 20.808

Review 2.  Extracellular matrix determinants of proteolytic and non-proteolytic cell migration.

Authors:  Katarina Wolf; Peter Friedl
Journal:  Trends Cell Biol       Date:  2011-10-27       Impact factor: 20.808

3.  TYRO3 as a potential therapeutic target in breast cancer.

Authors:  Roudy Chiminch Ekyalongo; Toru Mukohara; Yohei Funakoshi; Hideo Tomioka; Yu Kataoka; Yohei Shimono; Naoko Chayahara; Masanori Toyoda; Naomi Kiyota; Hironobu Minami
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

4.  The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase.

Authors:  G Izaguirre; L Aguirre; Y P Hu; H Y Lee; D D Schlaepfer; B J Aneskievich; B Haimovich
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

5.  α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts.

Authors:  Hanshuang Shao; James H-C Wang; Martin R Pollak; Alan Wells
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

Review 6.  Alpha-actinin structure and regulation.

Authors:  B Sjöblom; A Salmazo; K Djinović-Carugo
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

7.  A genomic screen identifies TYRO3 as a MITF regulator in melanoma.

Authors:  Shoutian Zhu; Heiko Wurdak; Yan Wang; Anna Galkin; Haiyan Tao; Jie Li; Costas A Lyssiotis; Feng Yan; Buu P Tu; Loren Miraglia; John Walker; Fanxiang Sun; Anthony Orth; Peter G Schultz; Xu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

8.  Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines.

Authors:  Stephen J Demarest; Jennifer Gardner; Michelle C Vendel; Eric Ailor; Suzanne Szak; Flora Huang; Adam Doern; Xiangyang Tan; Weixing Yang; Dorre A Grueneberg; Edward J Richards; Wilson O Endege; Ed Harlow; Louise A Koopman
Journal:  Biochemistry       Date:  2013-04-24       Impact factor: 3.162

9.  Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase.

Authors:  Chunhuai Wang; Ru Xiang; Xiangzhong Zhang; Yunxian Chen
Journal:  Mol Med Rep       Date:  2015-05-25       Impact factor: 2.952

10.  Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.

Authors:  Yukio Watabe; Taisuke Mori; Seiichi Yoshimoto; Takeshi Nomura; Takahiko Shibahara; Tesshi Yamada; Kazufumi Honda
Journal:  Cancer Med       Date:  2014-02-27       Impact factor: 4.452

View more
  6 in total

Review 1.  TYRO3: A potential therapeutic target in cancer.

Authors:  Pei-Ling Hsu; Jonathan Jou; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-02

Review 2.  Phosphorylation of key podocyte proteins and the association with proteinuric kidney disease.

Authors:  Di Feng
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-20

3.  TYRO3 facilitates cell growth and metastasis via activation of the Wnt/β-catenin signaling pathway in human gastric cancer cells.

Authors:  Dehu Chen; Qinghong Liu; Gan Cao; Wei Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

Review 4.  Role of ACTN4 in Tumorigenesis, Metastasis, and EMT.

Authors:  Dmitri Tentler; Ekaterina Lomert; Ksenia Novitskaya; Nikolai A Barlev
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

Review 5.  TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.

Authors:  Adam S Dayoub; Rolf A Brekken
Journal:  Cell Commun Signal       Date:  2020-02-22       Impact factor: 5.712

6.  Focal segmental glomerulosclerosis ACTN4 mutants binding to actin: regulation by phosphomimetic mutations.

Authors:  Hanshuang Shao; Bentley Wingert; Astrid Weins; Martin R Pollak; Carlos Camacho; Alan Wells
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.